These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38062484)

  • 1. The impact of the COVID-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis.
    Castanon A; Grasic K; Chen S; Ma F; Oboli G; Bray BD; Hughes A; White M; Ahmad S; Pearson-Stuttard J
    BMC Public Health; 2023 Dec; 23(1):2443. PubMed ID: 38062484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data.
    Hernandez I; He M; Guo J; Tadrous M; Gabriel N; Swabe G; Gellad WF; Essien UR; Saba S; Benjamin EJ; Magnani JW
    PLoS One; 2023; 18(2):e0281068. PubMed ID: 36730318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
    Kontopantelis E; Mamas MA; Webb RT; Castro A; Rutter MK; Gale CP; Ashcroft DM; Pierce M; Abel KM; Price G; Faivre-Finn C; Van Spall HGC; Graham MM; Morciano M; Martin GP; Sutton M; Doran T
    PLoS Med; 2022 Feb; 19(2):e1003904. PubMed ID: 35167587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on England's national prescriptions of oral vitamin K antagonist (VKA) and direct-acting oral anticoagulants (DOACs): an interrupted time series analysis (January 2019-February 2021).
    Alkhameys S; Barrett R
    Curr Med Res Opin; 2022 Jul; 38(7):1081-1092. PubMed ID: 35582854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England.
    Watkinson RE; Williams R; Gillibrand S; Munford L; Sutton M
    PLoS Med; 2023 Sep; 20(9):e1004289. PubMed ID: 37751419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on cardiovascular heart disease medication use: time-series analysis of England's prescription data during the COVID-19 pandemic (January 2019 to October 2020).
    Barrett R; Hodgkinson J
    Ther Adv Cardiovasc Dis; 2022; 16():17539447221137170. PubMed ID: 36420815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management.
    Dale CE; Takhar R; Carragher R; Katsoulis M; Torabi F; Duffield S; Kent S; Mueller T; Kurdi A; Le Anh TN; McTaggart S; Abbasizanjani H; Hollings S; Scourfield A; Lyons RA; Griffiths R; Lyons J; Davies G; Harris D; Handy A; Mizani MA; Tomlinson C; Thygesen JH; Ashworth M; Denaxas S; Banerjee A; Sterne JAC; Brown P; Bullard I; Priedon R; Mamas MA; Slee A; Lorgelly P; Pirmohamed M; Khunti K; Morris AD; Sudlow C; Akbari A; Bennie M; Sattar N; Sofat R;
    Nat Med; 2023 Jan; 29(1):219-225. PubMed ID: 36658423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset.
    Barrett R; Barrett R; Lin SX; Culliford D; Fraser S; Edwards CJ
    BMJ Open; 2022 Dec; 12(12):e051936. PubMed ID: 36564115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study.
    Miura R; Okada K
    Hypertens Res; 2023 Dec; 46(12):2593-2602. PubMed ID: 37463982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY.
    Russell MD; Massey J; Roddy E; MacKenna B; Bacon S; Goldacre B; Andrews CD; Hickman G; Mehrkar A; Mahto A; Rutherford AI; Patel S; Adas MA; Alveyn E; Nagra D; Bechman K; Ledingham JM; Hudson J; Norton S; Cope AP; Galloway JB
    Lancet Rheumatol; 2023 Oct; 5(10):e622-e632. PubMed ID: 38251486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink.
    Allan V; Sammon CJ; McDonald L; Mehmud F; Alikhan R; Ramagopalan SV
    Future Cardiol; 2019 Jul; 15(4):311-318. PubMed ID: 31241353
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing lipid management-impact of the COVID 19 pandemic upon cardiovascular risk in England.
    Newton JL; Hamed J; Williams H; Kearney M; Metcalfe AM; Ford GA
    Br Med Bull; 2023 Jun; 146(1):19-26. PubMed ID: 37170945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations.
    Gotanda H; Liyanage-Don N; Moran AE; Krousel-Wood M; Green JB; Zhang Y; Nuckols TK
    Hypertension; 2022 Dec; 79(12):2733-2742. PubMed ID: 36317526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic-insights from the German-wide Helios hospital network.
    Ueberham L; König S; Pellissier V; Hohenstein S; Meier-Hellmann A; Kuhlen R; Hindricks G; Bollmann A
    Eur Heart J Qual Care Clin Outcomes; 2021 May; 7(3):257-264. PubMed ID: 33729489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma and COPD medicines prescription-claims: A time-series analysis of England's national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020).
    Barrett R; Barrett R
    Expert Rev Respir Med; 2021 Dec; 15(12):1605-1612. PubMed ID: 34555287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study.
    Berge T; Lyngbakken MN; Ihle-Hansen H; Brynildsen J; Pervez MO; Aagaard EN; Vigen T; Kvisvik B; Christophersen IE; Steine K; Omland T; Smith P; Røsjø H; Tveit A
    BMJ Open; 2018 Aug; 8(7):e021704. PubMed ID: 30068617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on corticosteroids and antibiotics prescribing in England: an interrupted time series analysis.
    Chalitsios CV; McKeever TM; Langley TE; Shaw DE
    J Public Health (Oxf); 2021 Sep; 43(3):517-520. PubMed ID: 33539527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The road to recovery: an interrupted time series analysis of policy intervention to restore essential health services in Mexico during the COVID-19 pandemic.
    Doubova SV; Arsenault C; Contreras-Sánchez SE; Borrayo-Sánchez G; Leslie HH
    J Glob Health; 2022 Jul; 12():05033. PubMed ID: 35866236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of COVID-19 on Admissions and Management of Patients with Atrial Fibrillation Episodes in the Emergency Department.
    Bilaszewski Ł; Timler W; Budrewicz K; Marczak M; Kozłowski R; Wizowska J; Timler M; Jagielski D; Dudek M; Rasmus P; Zyśko D; Timler D
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34199795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation burden during the coronavirus disease 2019 pandemic.
    O'Shea CJ; Middeldorp ME; Thomas G; Harper C; Elliott AD; Ray N; Campbell K; Lau DH; Sanders P
    Europace; 2021 Sep; 23(9):1493-1501. PubMed ID: 34077513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.